|
||||||||||
Thank you for your phone call into Investor Relations.
GE, through its Healthcare business, provides a broad range of products and services to enable healthcare providers to better diagnose, treat and manage patients. This includes expertise in medical imaging, biopharmaceuticals, drug discovery and disease research. The company performs research in these areas in order to advance the state of the art of patient diagnosis and treatment.
GE Healthcare Position
- GE Healthcare has ongoing research, using both adult-derived stem cells and established embryonic stem (ES) cell lines, to investigate the practicality of developing novel methods of producing human cells that could be used in predictive drug screening applications. Better methods for evaluating drugs for safety (toxicity) and efficacy using human cells, will aid the development of more effective new medicines and could help reduce the need for testing some potential new medicines on animals.
- GE Healthcare continues to conduct research in accordance with US federal guidelines and UK legislation and recommendations regarding stem cell research. Our ES cell research programs are conducted in line with US federal guidelines recommending that research should employ previously established ES cell lines and adult tissue-derived stem cells. GE Healthcare will not be associated with the primary harvest of human embryo-derived cells or tissues.
- As many different laboratories have now grown established ES cell lines, GE Healthcare will work with recognized experts in this field and use established cell lines that are currently available or may in the future be established in accordance with prevailing US, UK government, or other applicable local guidelines.
- We acknowledge the considerable debate and take very seriously the ethical and societal issues associated with research using stem cells derived from embryonic or foetal tissue. We conduct our research in an ethically and scientifically responsible manner
We value your continuing interest in GE.
Pauline M. Berardi
GE
Specialist–Share Owner Information
T 203 373 2475
F 203 373 2071
D *229 2475
3135 Easton Turnpike
Fairfield, CT 06828, USA
Thank you for keeping us informed on all the poison they want to push on people and for trying to…
I expect Pope Francis and a number of bishops to come out with a statement saying that Catholics can in…
NO MORE VACCINES FOR US… no matter who make them or who pushes them.
Hi Lincoln, I’m curious what you meant in your above comment by “all the 3 letter B”? I assumed Bioengineered…
Hello, Thank you for your ministry. It provides needed answers to important questions. I pray God blesses you and COG.…
Thank you so much for the information on this vaccine! When will they stop!! Will pass the information on to…
No way I'll take this..I shall this article onto my friend here in Australia
Hi Larry! I know this is a few years old by now but I was reading through these comments and…
Thank you for the information! Pointing out the CI lower and upper bound prompted me to take a second look…
I do have your 2020 List of food products with senomyx and the list stated all refridgerated coffee creamers by…
They have been doing it. FYI https://www.nih.gov/news-events/news-releases/clinical-trial-mrna-universal-influenza-vaccine-candidate-begins
Excellent question, Eva. The flu shots are not re-developed every year and do not go through pre-clinical testing. The only…
From the article “Influenza Shots for 2024-2025 Season, it states “Like last year, none of the approved influenza shots, are…
The chart displays all of the currently approved influenza shots. Not all are trivalent. The viral composition for this year…
My understanding was that all 2024-2025 flu shots are trivalent, but the above chart still shows some quadrivalent.